SCM
IDXX icon

SG Capital Management’s Idexx Laboratories IDXX Stock Holding History

SG Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-181,766
Closed -$14.2M – 66
2016
Q1 		$14.2M Buy
+181,766
New +$13.1M 3.98% 3

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

SG Capital Management's IDXX Position: Q2 2016 in Review

SG Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2016, closing a stake of 181,766 shares — an estimated $14.2M sold.

SG Capital Management first reported a position in IDXX in Q1 2016 and held it in 1 quarter. The position peaked at $14.2M in Q1 2016. 437 funds tracked by Wall St. Rank hold IDXX as of Q2 2016.

  • SG Capital Management reported no remaining Idexx Laboratories position as of Q2 2016 after selling out during the quarter.
  • SG Capital Management sold 181,766 Idexx Laboratories shares in Q2 2016, an estimated $14.2M.
  • SG Capital Management first reported a position in Idexx Laboratories in Q1 2016 and held it in 1 quarter.
  • SG Capital Management's Idexx Laboratories position peaked at $14.2M in Q1 2016.
  • 437 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2016.

Based on SG Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.